Curaleaf Holdings (CURLF) Tax Provisions (2019 - 2026)

Curaleaf Holdings (CURLF) posted quarterly Tax Provisions of $98.7 million for Q1 2026, up 393.3% year-on-year from $20.0 million in Q1 2025, and down 55.57% on a QoQ basis from $222.2 million in Q4 2025.

Curaleaf Holdings (CURLF) Tax Provisions (2019 - 2026) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Tax Provisions for 8 consecutive years, with $98.7 million the latest figure, recorded in Q1 2026.

  • Quarterly Tax Provisions rose 393.3% year-over-year to $98.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.2 million (up 147.64% YoY) and the FY2025 annual result came in at $123.7 million, up 25.89% from the prior year.
  • Tax Provisions slipped to $98.7 million in Q1 2026 per CURLF's latest filing, from $222.2 million in the prior quarter.
  • Over the last five years, Tax Provisions for CURLF reached as high as $3.0 billion in Q4 2023 and fell as low as -$50.0 million in Q3 2022.
  • A 5-year average of $178.1 million and a median of -$31.9 million in 2023 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2023 — Tax Provisions soared 22084.03% — and 2024, when it sank 93.2%.
  • Year by year, Tax Provisions stood at -$13.5 million in 2022, then surged by 22084.03% to $3.0 billion in 2023, then plunged by 93.2% to $202.3 million in 2024, then climbed by 9.82% to $222.2 million in 2025, then tumbled by 55.57% to $98.7 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered $98.7 million, $222.2 million, and -$30.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 67.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 157.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 676.90 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -423.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 48.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 30.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn 98.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.71 Mn
Dec 31, 2025 222.16 Mn
Sep 30, 2025 -30.24 Mn
Jun 30, 2025 -31.38 Mn
Mar 31, 2025 -33.65 Mn
Dec 31, 2024 202.30 Mn
Sep 30, 2024 -32.57 Mn
Jun 30, 2024 -31.39 Mn
Mar 31, 2024 -40.09 Mn
Dec 31, 2023 2.97 Bn
Sep 30, 2023 -31.86 Mn
Jun 30, 2023 -41.95 Mn
Mar 31, 2023 -40.73 Mn
Dec 31, 2022 -13.53 Mn
Sep 30, 2022 -49.97 Mn
Jun 30, 2022 -49.16 Mn
Mar 31, 2022 -43.14 Mn
Dec 31, 2021 -35.13 Mn
Sep 30, 2021 -60.31 Mn
Jun 30, 2021 -42.62 Mn